<DOC>
	<DOCNO>NCT00988260</DOCNO>
	<brief_summary>The purpose study find optimal dose Org 37462 Japanese female undergo control ovarian stimulation vitro fertilization intracytoplasmic sperm injection ( IVF-ICSI ) .</brief_summary>
	<brief_title>Japanese Bridging Trial Org 37462 ( Study P05969 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Japanese female infertile married couple indication COH IVF without ICSI . At least 20 old 39 year age time screen . A body mass index ( BMI ) 18 29 . Normal menstrual cycle range 2435 day intraindividual variation plus minus 3 day ( never outside 2435 day range ) . Infertile couple willing give write informed consent . Determination inclusion criterion determine view plan therapeutic indication . determine base ethical consideration subject ( young 20 ) also view plan therapeutic indication ( old 39 ) determine avoid bias effect Org 37462 emaciation obesity . determine avoid influence endogenous hormone consider purpose trial select minimal effective dose Org 37462. determine ethical consideration subject . History of/or current endocrine abnormality polycystic ovary syndrome ( PCOS ) polycystic ovary accord USS , ( treat ) hyperprolactinemia evidence ovarian dysfunction . History non low ovarian response FSH/hMG treatment . Abnormal cervical smear accord Papanicolaou ( &gt; = class III ) Bethesda ( &gt; = CIN 1 ) scale . History of/or current Type I hypersensitivity ( urticaria , eczema , hay fever , asthma ) , mean subject use prescribed medication regular basis subject history prohibitive Org 37462 treatment accord clinical opinion subinvestigator . Any hormone value outside reference range early follicular phase measure central laboratory ( Japan ) [ FSH , LH , E2 , P , androstenedione ( AD ) , dehydroepiandrosterone sulphate ( DHEAS ) , testosterone ( T ) , thyroid stimulate hormone ( TSH ) prolactin ] . Any clinically significant abnormal laboratory value central laboratory ( Japan ) ( routine hematology , blood biochemistry ) . Any ovarian and/or abdominal abnormality would interfere adequate ultrasound investigation ovary , thus exclude subject one ovary . Contraindications use gonadotropin i.e. , tumor ovary , breast , uterus , pituitary hypothalamus . pregnancy lactation . undiagnosed vaginal bleeding . hypersensitivity substance recFSH ( FSH , sucrose , sodium citrate , polysorbate 20 sodium chloride , Lmethionine ) . ovarian cyst enlarge ovary relate PCOS . malformation sexual organ incompatible pregnancy . fibroid tumor uterus incompatible pregnancy . Use hormonal preparation within 1 month prior screen . Hypertension ( systolic blood pressure &gt; 150 mm Hg and/or diastolic blood pressure &gt; 90 mm Hg ) treat hypertension . Epilepsia , diabetes , cardiovascular , gastrointestinal , hepatic , renal , pulmonary , abdominal disease . Administration investigational drug within 3 month prior screen .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>